BIS vs. FFTY
Compare and contrast key facts about ProShares UltraShort Nasdaq Biotechnology (BIS) and Innovator IBD 50 ETF (FFTY).
BIS and FFTY are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BIS is a passively managed fund by ProShares that tracks the performance of the NASDAQ Biotechnology Index (-200%). It was launched on Apr 7, 2010. FFTY is a passively managed fund by Innovator that tracks the performance of the IBD 50 Index. It was launched on Apr 9, 2015. Both BIS and FFTY are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BIS vs. FFTY - Performance Comparison
Loading graphics...
BIS vs. FFTY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | -6.20% | -45.95% | 4.79% | -6.54% | -2.14% | -14.74% | -56.01% | -41.01% | 5.14% | -36.98% |
FFTY Innovator IBD 50 ETF | -4.02% | 23.38% | 18.36% | 12.40% | -51.08% | 11.92% | 18.20% | 25.74% | -16.76% | 37.62% |
Returns By Period
In the year-to-date period, BIS achieves a -6.20% return, which is significantly lower than FFTY's -4.02% return. Over the past 10 years, BIS has underperformed FFTY with an annualized return of -24.45%, while FFTY has yielded a comparatively higher 5.25% annualized return.
BIS
- 1D
- -8.92%
- 1M
- 5.69%
- YTD
- -6.20%
- 6M
- -31.27%
- 1Y
- -50.91%
- 3Y*
- -21.67%
- 5Y*
- -15.13%
- 10Y*
- -24.45%
FFTY
- 1D
- 5.00%
- 1M
- -18.29%
- YTD
- -4.02%
- 6M
- -9.38%
- 1Y
- 25.53%
- 3Y*
- 13.29%
- 5Y*
- -4.52%
- 10Y*
- 5.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIS vs. FFTY - Expense Ratio Comparison
BIS has a 0.95% expense ratio, which is higher than FFTY's 0.80% expense ratio.
Return for Risk
BIS vs. FFTY — Risk / Return Rank
BIS
FFTY
BIS vs. FFTY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and Innovator IBD 50 ETF (FFTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIS | FFTY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.09 | 0.74 | -1.83 |
Sortino ratioReturn per unit of downside risk | -1.73 | 1.14 | -2.87 |
Omega ratioGain probability vs. loss probability | 0.81 | 1.15 | -0.34 |
Calmar ratioReturn relative to maximum drawdown | -0.76 | 1.04 | -1.81 |
Martin ratioReturn relative to average drawdown | -1.06 | 3.05 | -4.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BIS | FFTY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.09 | 0.74 | -1.83 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | -0.16 | -0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.53 | 0.19 | -0.72 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.68 | 0.12 | -0.80 |
Correlation
The correlation between BIS and FFTY is -0.60. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Dividends
BIS vs. FFTY - Dividend Comparison
BIS's dividend yield for the trailing twelve months is around 4.91%, more than FFTY's 1.40% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 4.91% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% | 0.00% |
FFTY Innovator IBD 50 ETF | 1.40% | 1.35% | 0.91% | 0.65% | 2.75% | 0.22% | 0.00% | 0.00% | 0.00% | 0.17% |
Drawdowns
BIS vs. FFTY - Drawdown Comparison
The maximum BIS drawdown since its inception was -99.86%, which is greater than FFTY's maximum drawdown of -59.46%. Use the drawdown chart below to compare losses from any high point for BIS and FFTY.
Loading graphics...
Drawdown Indicators
| BIS | FFTY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.86% | -59.46% | -40.40% |
Max Drawdown (1Y)Largest decline over 1 year | -64.06% | -23.29% | -40.77% |
Max Drawdown (5Y)Largest decline over 5 years | -73.87% | -59.46% | -14.41% |
Max Drawdown (10Y)Largest decline over 10 years | -95.07% | -59.46% | -35.61% |
Current DrawdownCurrent decline from peak | -99.85% | -32.35% | -67.50% |
Average DrawdownAverage peak-to-trough decline | -89.92% | -22.38% | -67.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.28% | 7.97% | +38.31% |
Volatility
BIS vs. FFTY - Volatility Comparison
ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 17.39% compared to Innovator IBD 50 ETF (FFTY) at 14.46%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than FFTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BIS | FFTY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.39% | 14.46% | +2.93% |
Volatility (6M)Calculated over the trailing 6-month period | 29.15% | 28.72% | +0.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.18% | 34.49% | +12.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.50% | 29.00% | +14.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.64% | 27.17% | +19.47% |